Mouse Anti-KCNT1 Recombinant Antibody (S3-26) (CBMAB-K0063-LY)

Basic Information
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
A rare epileptic encephalopathy of infancy that combines pharmacoresistant seizures with developmental delay. This severe neurologic disorder is characterized by onset in the first 6 months of life of refractory focal seizures and arrest of psychomotor development. Ictal EEG shows discharges that arise randomly from various areas of both hemispheres and migrate from one brain region to another.
Epilepsy, nocturnal frontal lobe, 5 (ENFL5):
An autosomal dominant focal epilepsy syndrome characterized by childhood onset of clusters of motor seizures during sleep. Some patients may develop behavioral or psychiatric manifestations and/or intellectual disability. The phenotype is more severe than observed in other genetic forms of nocturnal frontal lobe epilepsy.
Helical: 98-118
Extracellular: 119-155
Helical: 156-176
Cytoplasmic: 177-187
Helical: 188-208
Extracellular: 209-213
Helical: 214-226
Cytoplasmic: 227-251
Helical: 252-272
Extracellular: 273-281
Pore-forming: 282-302
Extracellular: 303-304
Helical: 305-325
Cytoplasmic: 326-1230
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us
